BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37551941)

  • 1. Urine drug testing in the context of opioid analgesic prescribing for chronic pain: a content analysis of U.S. state laws in 2022.
    Andraka-Christou B; McAvoy E; Gordon AJ; Ohama M; Brach M; Taylor EA; Vaiana M; Saloner B; Stein BD
    Pain Med; 2023 Dec; 24(12):1306-1317. PubMed ID: 37551941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of the Current State of Urine Drug Testing in Chronic Pain: Still Effective as a Clinical Tool and Curbing Abuse, or an Arcane Test?
    Chakravarthy K; Goel A; Jeha GM; Kaye AD; Christo PJ
    Curr Pain Headache Rep; 2021 Feb; 25(2):12. PubMed ID: 33598816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinician Response to Aberrant Urine Drug Test Results of Patients Prescribed Opioid Therapy for Chronic Pain.
    Morasco BJ; Krebs EE; Adams MH; Hyde S; Zamudio J; Dobscha SK
    Clin J Pain; 2019 Jan; 35(1):1-6. PubMed ID: 30222612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do Urine Drug Tests Reveal Substance Misuse Among Patients Prescribed Opioids for Chronic Pain?
    Larochelle MR; Cruz R; Kosakowski S; Gourlay DL; Alford DP; Xuan Z; Krebs EE; Yan S; Lasser KE; Samet JH; Liebschutz JM
    J Gen Intern Med; 2022 Aug; 37(10):2365-2372. PubMed ID: 34405344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of urine drug testing for patients with chronic pain: Results from a national cohort of U.S. veterans.
    Morasco BJ; Peters D; Krebs EE; Kovas AE; Hart K; Dobscha SK
    Subst Abus; 2016; 37(1):82-7. PubMed ID: 26516794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine Drug Testing Among Patients Prescribed Long-Term Opioid Therapy: Patient and Clinician Factors.
    Agnoli AL; Howe R; Magnan E; Jerant A; Colby D; Franks P
    J Am Board Fam Med; 2023 Aug; 36(4):537-541. PubMed ID: 37468213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shorter drug testing intervals are associated with improved drug misuse rates.
    Gudin J; Mehta N; McClure FL; Niles JK; Kaufman HW
    J Opioid Manag; 2020 Sep/Oct 2020; 16(5):357-373. PubMed ID: 33226093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment changes following aberrant urine drug test results for patients prescribed chronic opioid therapy.
    Morasco BJ; Krebs EE; Cavanagh R; Hyde S; Crain A; Dobscha SK
    J Opioid Manag; 2015; 11(1):45-51. PubMed ID: 25750164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine Drug Testing in Cancer Pain Management.
    Arthur JA
    Oncologist; 2020 Feb; 25(2):99-104. PubMed ID: 32043770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
    Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of the accuracy of immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing (UDT) opioids and illicit drugs in chronic pain patients.
    Manchikanti L; Malla Y; Wargo BW; Fellows B
    Pain Physician; 2011; 14(2):175-87. PubMed ID: 21412372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine drug testing: current recommendations and best practices.
    Owen GT; Burton AW; Schade CM; Passik S
    Pain Physician; 2012 Jul; 15(3 Suppl):ES119-33. PubMed ID: 22786451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory-Generated Urine Toxicology Interpretations: A Mixed Methods Study.
    Chua IS; Ransohoff JR; Ehrlich O; Katznelson E; Virk ZM; Demetriou CA; Petrides AK; Orav EJ; Schiff GD; Melanson SEF
    Pain Physician; 2021 Mar; 24(2):E191-E201. PubMed ID: 33740356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urine drug testing in chronic pain.
    Christo PJ; Manchikanti L; Ruan X; Bottros M; Hansen H; Solanki DR; Jordan AE; Colson J
    Pain Physician; 2011; 14(2):123-43. PubMed ID: 21412368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Describing prescription opioid adherence among individuals with chronic pain using urine drug testing.
    Matteliano D; Chang YP
    Pain Manag Nurs; 2015 Feb; 16(1):51-9. PubMed ID: 24939349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of State Opioid Prescribing Laws on Use of Opioid and Other Pain Treatments Among Commercially Insured U.S. Adults.
    McGinty EE; Bicket MC; Seewald NJ; Stuart EA; Alexander GC; Barry CL; McCourt AD; Rutkow L
    Ann Intern Med; 2022 May; 175(5):617-627. PubMed ID: 35286141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. State pain management clinic policies and county opioid prescribing: A fixed effects analysis.
    Frizzell LC; Vuolo M; Kelly BC
    Drug Alcohol Depend; 2020 Nov; 216():108239. PubMed ID: 32854001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
    Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
    Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic urine drug testing for detecting and managing opioid misuse among chronic noncancer pain patients in primary care-The HARMS Program: A retrospective chart review of 77 patients.
    Shahi N; Patchett-Marble R
    J Opioid Manag; 2020; 16(4):277-282. PubMed ID: 32885835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Random urine drug testing among patients receiving opioid therapy for cancer pain.
    Arthur JA; Tang M; Lu Z; Hui D; Nguyen K; Rodriguez EM; Edwards T; Yennurajalingam S; Dalal S; Dev R; Reddy A; Tanco K; Haider A; Liu DD; Bruera E
    Cancer; 2021 Mar; 127(6):968-975. PubMed ID: 33231885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.